• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泪液中12种细胞因子和生长因子的水平:甲状腺功能亢进与甲状腺功能正常的比较

The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

作者信息

Mandić Jelena Juri, Kozmar Ana, Kusačić-Kuna Sanja, Jazbec Anamarija, Mandić Krešimir, Mrazovac Danijela, Vukojević Nenad

机构信息

Department of Ophthalmology, Clinical Hospital Centre Zagreb, Medical School University of Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.

Department of Laboratory Diagnostics, Clinical Hospital Centre Zagreb, Zagreb, Croatia.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):845-852. doi: 10.1007/s00417-017-3892-6. Epub 2018 Jan 14.

DOI:10.1007/s00417-017-3892-6
PMID:29332250
Abstract

PURPOSE

Simultaneous analyses of the contents and ratios of 12 cytokines and growth factors in single samples of human tears were performed, and the results were compared between a group of healthy subjects and a group of patients with Graves' hyperthyreosis (GH) without thyroid-associated orbitopathy (TAO).

METHODS

Determinations and concentration measurements of interleukins (IL-2, IL4, IL-6, IL-8, IL-10, IL-1α, and IL-1β) interferon (IFN-γ), tumor necrosis factor (TNF-α), monocyte chemoattractant protein (MCP-1), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF) were performed with single tear samples from 21 patients with hyperthyreosis and 22 healthy subjects. The analyses were performed using a Randox microchip with an Evidence Biochip Array Analyzer.

RESULTS

We found significant differences between the healthy donor group and the hyperthyreosis group in the levels of IL-6, IL-10, VEGF, IL-1α, and MCP-1. The concentration of IL-6 was considerably higher in the hyperthyreosis group, IL-10 was higher in the healthy donor group, and VEGF and MPC-1 were higher in the hyperthyreosis group. The IL-8 and IFN-γ levels were higher in the hyperthyreosis group. The ratios of all of the cytokines to anti-inflammatory IL-10 were significantly elevated in the hyperthyreosis group.

CONCLUSION

There are clear differences in the levels of cytokines and growth factors in the tears of healthy subjects and patients with GH without TAO. Tear cytokine changes and related dysfunctional tear syndrome (DTS) could be an early sign of occult TAO in Graves' hyperthyreosis patients.

摘要

目的

对人眼泪单一样本中的12种细胞因子和生长因子的含量及比例进行同步分析,并比较健康受试者组与一组无甲状腺相关眼病(TAO)的格雷夫斯甲状腺功能亢进症(GH)患者之间的结果。

方法

对21例甲状腺功能亢进症患者和22例健康受试者的单份眼泪样本进行白细胞介素(IL-2、IL4、IL-6、IL-8、IL-10、IL-1α和IL-1β)、干扰素(IFN-γ)、肿瘤坏死因子(TNF-α)、单核细胞趋化蛋白(MCP-1)、血管内皮生长因子(VEGF)和表皮生长因子(EGF)的测定及浓度测量。使用带有Evidence生物芯片阵列分析仪的兰道克斯微芯片进行分析。

结果

我们发现健康供体组和甲状腺功能亢进症组在IL-6、IL-10、VEGF、IL-1α和MCP-1水平上存在显著差异。甲状腺功能亢进症组中IL-6的浓度明显更高,健康供体组中IL-10更高,而甲状腺功能亢进症组中VEGF和MPC-1更高。甲状腺功能亢进症组中IL-8和IFN-γ水平更高。甲状腺功能亢进症组中所有细胞因子与抗炎性IL-10的比例均显著升高。

结论

健康受试者和无TAO的GH患者眼泪中的细胞因子和生长因子水平存在明显差异。眼泪细胞因子变化及相关的功能性泪液综合征(DTS)可能是格雷夫斯甲状腺功能亢进症患者隐匿性TAO的早期迹象。

相似文献

1
The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.泪液中12种细胞因子和生长因子的水平:甲状腺功能亢进与甲状腺功能正常的比较
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):845-852. doi: 10.1007/s00417-017-3892-6. Epub 2018 Jan 14.
2
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.年龄相关性白内障患者泪液中细胞因子和趋化因子浓度。
Curr Eye Res. 2020 Sep;45(9):1101-1106. doi: 10.1080/02713683.2020.1715445. Epub 2020 Jan 24.
3
Cytokine and chemokine tear levels in patients with uveitis.葡萄膜炎患者泪液中细胞因子和趋化因子水平
Acta Ophthalmol. 2017 Aug;95(5):e405-e414. doi: 10.1111/aos.13292. Epub 2016 Nov 22.
4
Determination of tear and serum inflammatory cytokines in patients with rosacea using multiplex bead technology.采用多重微球技术测定酒渣鼻患者的泪液和血清炎症细胞因子。
Ocul Immunol Inflamm. 2013 Oct;21(5):351-9. doi: 10.3109/09273948.2013.795229. Epub 2013 Jun 3.
5
Tear cytokine profiles in dysfunctional tear syndrome.功能失调性泪液综合征中的泪液细胞因子谱
Am J Ophthalmol. 2009 Feb;147(2):198-205. e1. doi: 10.1016/j.ajo.2008.08.032. Epub 2008 Nov 7.
6
Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.眼部慢性移植物抗宿主病中的生物标志物:基于泪液细胞因子和趋化因子的预测模型。
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):746-58. doi: 10.1167/iovs.15-18615.
7
Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.甲状腺相关眼病泪液中细胞因子谱。
Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):619-25. doi: 10.1007/s00417-011-1863-x. Epub 2011 Nov 30.
8
Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.蒸发型干眼疾病中泪液细胞因子和趋化因子分析及其与临床的相关性
Mol Vis. 2010 May 19;16:862-73.
9
Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.格雷夫斯眼病导致泪液成分发生深刻变化:纤溶酶原激活物抑制剂-1 和七种细胞因子的研究。
Thyroid. 2012 Apr;22(4):407-14. doi: 10.1089/thy.2011.0248. Epub 2012 Mar 2.
10
Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.甲状腺相关眼病患者泪液细胞因子的差异分析。
Sci Rep. 2018 Jul 17;8(1):10792. doi: 10.1038/s41598-018-29113-2.

引用本文的文献

1
The ocular surface tear film as a biomarker for systemic health.眼表泪膜作为全身健康的生物标志物。
Ocul Surf. 2025 Jul;37:283-300. doi: 10.1016/j.jtos.2025.05.005. Epub 2025 May 8.
2
Hashimoto's Thyroiditis and Dry Eye Disease.桥本甲状腺炎与干眼症
J Clin Med. 2025 Mar 4;14(5):1710. doi: 10.3390/jcm14051710.
3
Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy.非活动期轻度及中重度格雷夫斯眼眶病眼表刺激症状的危险因素

本文引用的文献

1
Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.Th1、Th2和Th17细胞因子与甲状腺相关性眼病的关系
Dis Markers. 2015;2015:609593. doi: 10.1155/2015/609593. Epub 2015 May 18.
2
Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside.细胞因子在甲状腺相关性眼病中既是“反派”,又是潜在的治疗靶点:从实验室到临床应用
Expert Rev Ophthalmol. 2014 Jun;9(3):227-234. doi: 10.1586/17469899.2014.917960.
3
Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.
Ophthalmol Ther. 2024 Apr;13(4):1015-1024. doi: 10.1007/s40123-024-00892-4. Epub 2024 Feb 20.
4
Nonsurgical treatment for upper eyelid retraction in patients with inactive Graves' orbitopathy.非手术治疗活动性 Graves 眼病患者的上睑退缩。
Int Ophthalmol. 2023 Jul;43(7):2291-2299. doi: 10.1007/s10792-022-02625-7. Epub 2023 Jan 1.
5
Mechanisms of immune-related differentially expressed genes in thyroid-associated ophthalmopathy based on the GEO database.基于GEO数据库的甲状腺相关眼病中免疫相关差异表达基因的机制
Ann Transl Med. 2022 Sep;10(17):926. doi: 10.21037/atm-22-3470.
6
Autologous Platelet-Rich Plasma Drops for Evaporative Dry Eye Disease from Meibomian Gland Dysfunction: A Pilot Study.自体富血小板血浆滴眼液治疗睑板腺功能障碍所致蒸发型干眼疾病的一项初步研究。
Clin Ophthalmol. 2022 Jul 6;16:2199-2208. doi: 10.2147/OPTH.S367807. eCollection 2022.
7
Ocular surface disease in thyroid eye disease: A narrative review.甲状腺眼病中的眼表面疾病:叙述性综述。
Ocul Surf. 2022 Apr;24:67-73. doi: 10.1016/j.jtos.2022.02.001. Epub 2022 Feb 12.
8
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.非感染性角膜损伤的治疗:诊断试剂、治疗药物及未来靶点的综述。
Drugs. 2022 Feb;82(2):145-167. doi: 10.1007/s40265-021-01660-5. Epub 2022 Jan 13.
9
Thyroid function in COVID-19 and the association with cytokine levels and mortality.2019冠状病毒病中的甲状腺功能及其与细胞因子水平和死亡率的关联。
Endocr Connect. 2021 Sep 28;10(10):1234-1242. doi: 10.1530/EC-21-0301.
10
The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.纤溶酶原激活物抑制剂1的4G/5G多态性是中重度甲状腺眼病的一个预测指标。
J Inflamm Res. 2021 May 12;14:1883-1890. doi: 10.2147/JIR.S307046. eCollection 2021.
甲状腺相关性眼病中泪腺及泪液炎症细胞因子的变化
Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):4935-43. doi: 10.1167/iovs.13-13704.
4
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.甲状腺相关性眼病的分子发病机制的当前概念。
Invest Ophthalmol Vis Sci. 2014 Mar 20;55(3):1735-48. doi: 10.1167/iovs.14-14002.
5
Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome.干眼症患者泪液中Th17相关细胞因子的分析
Eye (Lond). 2014 May;28(5):608-13. doi: 10.1038/eye.2014.38. Epub 2014 Mar 7.
6
Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.局部应用白介素 1 受体拮抗剂治疗干眼:一项随机临床试验。
JAMA Ophthalmol. 2013 Jun;131(6):715-723. doi: 10.1001/jamaophthalmol.2013.195.
7
Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease.眼表细胞外 DNA 和核酸酶活性失衡:干眼症炎症的新范式。
Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8253-63. doi: 10.1167/iovs.12-10430.
8
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.眼表面免疫:干眼症中稳态机制及其破坏。
Prog Retin Eye Res. 2012 May;31(3):271-85. doi: 10.1016/j.preteyeres.2012.02.003. Epub 2012 Mar 8.
9
Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.格雷夫斯眼病导致泪液成分发生深刻变化:纤溶酶原激活物抑制剂-1 和七种细胞因子的研究。
Thyroid. 2012 Apr;22(4):407-14. doi: 10.1089/thy.2011.0248. Epub 2012 Mar 2.
10
Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.甲状腺相关眼病泪液中细胞因子谱。
Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):619-25. doi: 10.1007/s00417-011-1863-x. Epub 2011 Nov 30.